ArticleCancer immunology, immunotherapy : CII2026

Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: implications for their interaction and clinical outcome.

Hiroyuki Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.